The pyrrolidinomorphinane derivatives have been found to be active in the writhing tests in mice with the analgesic effect being antagonized by naloxone. This suggests that analgesia is mediated by the opioid system. The compounds also displayed anti-inflammatory activity in formalin and histamine edema experimental models and the data may be evidence for antiinflammatory activity involvement in the inhibition of pain reaction.
The addition of heterocyclic fragments into the molecules of morphinane alkaloids is a perspective approach to their synthetic transformation. This has allowed the production of a number of opioid agents, including selective agonists and antagonists of µ-, δand κ-opioid receptors [1] [2] [3] . There is some evidence for high analgesic activity of morphinane derivatives containing a С-7,8-fused heterocyclic fragment [4] . However, despite some of these derivatives having been proved to be highly active, the mechanism of their analgesic activity has not been yet studied.
The analgesic activity mechanisms of two pyrrolidinomorphinane derivatives have been studied.. Agent I [7,8- (N-phenylpyrrolidino)tetrahydrooripavin] and agent II [7,8- [N-(pbromophenyl)-pyrrolidino]-tetrahydrooripavin] have been selected from 24 synthesized morphinane derivatives as having the largest activity. The difference between the two selected agents is the presence of a bromine atom in the aryl moiety of the pyrrolidine fragment of agent II.
The antinociceptive properties of the pyrrolidinomorphinane derivatives were assessed in two visceral pain models in which writhing was induced by injection of either acetic acid or acetylcholine. As shown in Figure 1 , compounds I and II completely inhibited both acetic acid and acetylcholine induced writhing. This suggests that both the chemicals entirely prevented pain reaction development induced by peritoneal chemical irritation. This inhibitory effect was similar to the one observed in the control indometacin treated group and exceeded the antinociceptive effect of the opioid analgesic piritramide (in a therapeutic dose of 0.1 mg/kg) in both writhing tests.
It is known that narcotic analgesics can inhibit writhing in the studied models (induced by acetic acid and acetylcholine), and their antinociceptive activity is prevented by injection of the opioid receptor antagonist naloxone [5] . Because of this, naloxone has been used in an attempt to antagonize the analgesic response induced by the test agents. Naloxone injection diminished the analgesic effect of agents I and II in the acetic acid writing test by 28 and 29%, respectively ( Figure 1А ). In the acetylcholine writhing test, naloxone injection did not affect agent I induced pain inhibition, whereas with agent II, the analgesic effect was entirely suppressed ( Figure 1B) . At the same time, naloxone disrupted the antinociceptive activity of the opioid analgesic piritramide by 85.0% and 77.8% in the acetic acid and acetylcholine writhing tests, respectively. The incomplete prevention of the antinociceptive effect in the acetic acid writhing test in the naloxone treated animals suggested that the opioid system might be responsible for the antinociceptive effect observed after agent injection in this test. On the other hand, it can be speculated that pathways other than the opioid one could also be involved as naloxone treatment failed to inhibit completely the agent induced analgesic effect.
The complete inhibition produced by agent II in the acetylcholine writhing test after naloxone injection leads to the suggestion that analgesia can be mediated by the opioid system. On the contrary, naloxone failure to block analgesia when using agent I speculates for the absence of opioid system involvement in acetylcholine writhing inhibition. This puzzling contradiction in analgesic response using two different agents, despite the equal impact for opioid and non-opioid pathways in the acetic acid writhing test for both agents, may be considered from different points of view. On one hand, both tests are considered as visceral pain models, but acetic acid and acetylcholine injections also result in inflammatory responses, and the nociceptive mechanisms triggered in each model are different. On the other hand, agent II is chemically distinct from agent I due to the presence of a bromine atom in the aryl moiety of the pyrrolidine fragment. This structure difference can probably explain the fact that, in the acetylcholine writhing test, the opioid pathway is inherent for agent II, while agent I analgesia is mostly mediated by some other activity, possibly antiinflammatory.
To test this hypothesis it was decided to investigate the anti-inflammatory activity of the two test agents using two edema models. As shown in Figure 2 , agent I was able to reduce formalin-induced inflammation by 17%, but was less effective when compared with indometacin, which was used as a control (Figure 2A) . At the same time, both agents decreased histamine-induced inflammation by 56% and 43%, respectively, being more effective than indometacin ( Figure 2B ). Thus, it has been concluded that, in addition to the analgesic response alone, pyrrolidinomorphinane derivatives also show an antiinflammatory response, which explains the additional non-opioid analgesic activity in the visceral pain tests.
These data support the efficiency of pyrrolidinomorphinane derivatives in mediating the high analgesic response when using visceral pain tests. The opioid system is one of the systems involved in the analgesic action of the investigated compounds. The anti-inflammatory activity produced by agents I and II can also mediate pain inhibition. The presence of a bromine atom in the aryl moiety of the pyrrolidine fragment leads to the conclusion that the opioid pathway of analgesia is the only one involved in the acetylcholine-induced writhing test and for the decreased anti-inflammatory effect in formalin-and histamine-induced edema.
Experimental
General: Test agents I and II were designed and synthesized in the Laboratory of Medical Chemistry (N.N.Vorozhtsov Institute of Organic Chemistry SB RAS, Novosibirsk) [6] . The synthesis of the compounds started with the Diels-Alder reaction of thebaine (III) with N-substituted maleimides (IVa,b). The interaction of the components proceeds in ethanol solution with the formation of 7,8succinimido-6,14-endo-ethenotetrahydro-thebaines (V, VI), yielding about 91-96%. As revealed by the 1 H NMR spectroscopic data, all the compounds are the products of the β-face endo-approach. Typical of the stereochemistry of the Diels-Alder products is the example of the W-coupling of H 5 with H 17 (approx. 1.5 Hz). Experimental results are fully compatible with frontier molecular orbital considerations [7] . Reduction of adducts V and VI with an excess of lithium aluminum hydride gave the 7,8-pyrrolidino-6,14-endo-ethenotetrahydrothebaines VII and VIII (yield 82-88%). Treatment of compounds VII and VIII under standard demethylation conditions using boron tribromide in dry chloroform leads to the formation of the 3-hydroxy derivatives I and II. All new compounds gave satisfactory analytical and spectroscopic (MS, NMR, UV) data. Selected spectroscopic data for the new compounds are supplied [8] .
Analgesic tests: Agents were dissolved in saline containing 0.5% Tween 80 just before use and 5 mg/kg doses were administered p.o. 1 h before testing. Naloxone (Sigma) was administered (dose1 mg/kg s.c.) 50 min after administration of the test agents (10 min before testing). Piritramide (Dipidolor, Gedeon Richter) at a dose of 0.1 mg/kg s.c. and indometacin (ICN Biomedicals Inc.) at 15 mg/kg p.o. were used as controls, and administered using the same scheme as for the test compounds.
Analgesic activity of test agents was assessed using two writhing tests induced by acetic acid and acetylcholine [9, 10] . Pain reaction was determined by the number of abdominal writhing movements, recorded from the 5 th to the 10 th min after acetic acid injection (0.75%, 0.1 mL/mouse) or during the first 5 min after acetylcholine injection (0.3 mg/0.1 mL/ 10 g). The percentage of pain reaction inhibition was calculated according to the following equation: % inhibition = 100 х (А -B)/А, where А is the mean number of writhes in the control group, and B is the mean number of writhes in the test group.
Anti-inflammatory activity:
Anti-inflammatory activity of the compounds was studied in two inflammation models induced by injection of either 3% formalin or 0.1% histamine (0.05 mL) into the aponeurosis of the hind limb [11] . Test compounds were administered three times: 1 h before injection of the inflammatory agent and 1 and 2 h afterwards. The total dose used for each agent was 15.0 mg/kg, and the total dose for indometacin 45 mg/kg. Mice were killed 5 h after the inflammatory episode; hind limbs were cut off and weighed. Inflammation percentage was calculated by the equation: % inflammation = 100 x (M il -M nil )/M nil ; where M il is the inflamed limb mass, and M nil the non-inflamed limb mass.
Statistical analysis was performed using one-way ANOVA with the assistance of Origin 7.0 software. Differences between groups were considered significant at P<0.05.
Animal material:
All studies were carried out on non-breeding albino mice in accordance with The Guideline for the Care and Use of Laboratory Animals. Mice, 20-25 g body weight, were obtained from the Institute of Cytology and Genetics SB RAS, Novosibirsk and housed in an appropriate cage facility with food and water ad libitum.
